The Binaytara Foundation’s 4th International Cancer Congress Brings Latest Cancer Care Research To South Asia

Janakpurdham, Nepal, April 27, 2022 – The Binaytara Foundation hosted its Fourth International Cancer Congress on April 16, bringing together scientists and healthcare workers to share the latest findings in cancer care. This educational meeting had the goal of improving the care of cancer patients in South Asia by educating cancer care providers about the latest developments in the field, and their applications in the local context. This year’s event resulted in the presentation of numerous papers or studies on the topic, and two presenters received awards for their work:

  • The Staff of the Year Award was presented to Mrs. Ruchika Shrestha for her hard work and dedication to improving patient care. Mrs. Shrestha has been working with the BTFCC since its inception in December 2018. She communicates well with patients and their families to understand their socio-economic aspects while also making them feel comfortable emotionally, which strengthens the bond between patients and care professionals. She manages and teaches new nursing staff, contributing to better coordination.
  • The Young Scientist Award was presented to Dr. Nirajan Subedi for the abstract “Post-Operative Pancreatitis as a Predictor of Post-Operative Pancreatic Fistula in Patients Following Pancreaticoduodenectomy in a University Hospital in Nepal.” This paper was presented at the conference.

The 4th International Cancer Congress

The agenda included a breast cancer session, several general oncology sessions, an abstract session, a keynote address on communication, and the award ceremony.

“The 4th International Cancer Congress is an important way for leaders in cancer care to share the latest research and advances to improve cancer care in South Asia,” said Dr. Binay Shah, president of the Binaytara Foundation. “It’s an honor to congratulate our award winners, and thank everyone who contributed to the conference. We appreciate the hard work of each person who shared a paper at this congress, and we encourage others to submit to our medical journal throughout the year. It helps us to disseminate research beyond those who can attend the conference, and there is no fee to submit.”

 

 

About Binaytara Foundation:

Binaytara Foundation is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. Binaytara Foundation’s major projects include hematology and oncology conferences, and the establishment of a cancer hospital in Nepal.

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

5 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

5 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

6 months ago